dc.description.abstract |
The glucose-6-phosphate dehydrogenase (G6PD) enzyme is a vital enzyme of pentose phosphate
pathway involved in the conversion of glucose-6-phosphate (G6P) to 6-phosphogluconolactone,
as well as in reducing NADP+
to NADPH. The enzyme acts as a double end sword where its
deficiency leads to a condition commonly known as G6PD deficiency causing hemolytic anemia
neonatal jaundice and kernicterus. On the other hand, over expression of G6PD leads to increased
cellular growth and carcinogenesis. Therefore; detailed understanding of induction and inhibition
mechanism of G6PD enzyme is required. Induction may bring about increased enzymatic activity
leading to enhanced production of cellular machinery and enhanced cellular growth resulting in
tumorigenesis; conversely inhibition mechanism leads to deficiency of varying degree leading to
several clinical manifestations. This thesis aims to advance our mechanistic and molecular level
understanding of G6PD enzyme.
Computational enzymology has become an emerging field in recent years for investigation of
enzyme activity since it allows the calculation of the energies and structures of short-lived
intermediates and transition states. Different chemical pathways can be studied using
computational enzymology, and their validity can be determined by thoroughly evaluating
predicted energy barriers. Molecular level picture provides physical basis of structure and function
of protein/enzyme. During the chemical process, a change in electronic structure of species at
reactive site of enzyme may occur. Cluster modeling approach is one of the powerful tool in
computational enzymology used for modeling the active site of enzyme and investigation of
reaction mechanisms. Mechanism of G6PD enzyme and associated reaction energetics have been
explored in this thesis by employing cluster modeling approach using M06-2X functional.
Reaction energetics have been compared to get an insight in to the catalytic role of Asp246-
residue
in the active site with neutral, protonated and deprotonated Histidine (His309). Proton abstraction
from His309 by Asp246-
adopts a multistep sequential mechanism with a low energy barrier
indicating its ultimate role in catalysis.
Proteins structures remain dynamic to accommodate substrate binding giving rise to changes in
the local and global dynamics of enzyme during the course of reaction. Understanding the
dynamical behavior of protein is critical in grasping the functionality and protein stability. Several
Abstract
xv
biochemical experimental techniques such as structural, biochemical, kinetic and spectroscopic
characterization have advanced in solving the mystery of molecular mechanisms considerably.
However; employing molecular dynamics simulations in understanding the dynamical behavior of
protein and its effect on functionality by using experimentally solved crystal structures is a good
starting point which has been employed in this thesis. Location of mutation in three-dimensional
structure of protein is critical in determining the shape and structural integrity of enzyme. In G6PD
dimer interface and structural NADP+
binding site has been known for structural integrity of
enzyme since long. Dynamical properties for wildtype G6PD and three of its mutants have been
compared to explore the effect of location of mutation on enzyme structure with respect to
structural NADP+
binding site.
Enzyme catalyzed reactions occur in complex environment consisting of several rearrangements
in addition to bond making and breaking. QC/MM methods with ab-initio quantum mechanics
with MD simulation are the powerful and accurate methods to identify the reaction mechanism
and associated dynamical changes of enzyme catalyzed reaction which require large computational
time. Nevertheless to reduce the computational cost; Semi-empirical methods are popular for
understanding reaction site mechanism at atomistic level with associated dynamics. Semi-
empirical QC/MM methods have been implemented in this thesis to explore the reaction
mechanism of G6PD in the presence of surrounding environment. The most important moieties
proposed in reaction mechanism including nicotinamide ring atoms of NADP+, all G6P atoms,
imidazole ring of catalytic and activating His309 and amine group of Lys145 were included in QC
region whereas a mobile and fixed region was setup around catalytic center. Catalytic mechanism
validated proton abstraction role of Asp246 as observed in cluster modeling approach.
Computer aided drug discovery is a breakthrough in the field of drug development which have
expedited this lengthy process in various aspects. The discovery and development of novel
therapeutic agents in oncology has resulted in considerably improved survival rates for many types
of cancer. G6PD plays a significant role in cellular proliferation in various forms of cancers.
Among the various cancer treatment regimes, inhibition of G6PD to stop production of cancer
cells remained under debate since long. Several steroid inhibitors formulated against G6PD have
been shown to improve anticancer treatment and effective against drug resistance. However,
similar to several anticancer drugs, requirement of higher concentration of effective dose of drug
Abstract
xvi
reduces the efficacy of treatment. Information regarding inhibitory site of G6PD is unclear in
literature. The steroid inhibitors have been reported to un-competitively inhibit G6PD elucidating
allosteric nature of these inhibitors. Therefore, an attempt has been made to identify the potent
inhibitory binding site of G6PD for effective inhibitor binding. Moreover, optimal features for
G6PD inhibition have been formulated using ligand based pharmacophore modeling approach.
Our developed a pharmacophore model based on docking studies and preferred inhibitory site was
complementary to the receptor site. Our developed model can help to design better drug targets for
future rational drug design. The results obtained from mechanistic and dynamics studies can give
an insight in to further development of inhibitory molecules with better targeted binding and
inhibition of G6PD for development of antitumor therapies. |
en_US |